Drugs and Devices

FDA allows marketing of ‘next generation’ gene sequencing devices

On Nov. 19, the U.S. Food and Drug Administration (FDA) allowed marketing of four diagnostic devices that can be used for high throughput gene sequencing, often referred to as “next generation sequencing” (NGS). Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares